|
IKZF2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.681000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.901000E-01 |
| Normal-vs-Stage2 |
9.101800E-01 |
| Normal-vs-Stage3 |
1.197830E-01 |
| Normal-vs-Stage4 |
5.822800E-01 |
| Stage1-vs-Stage2 |
9.125000E-01 |
| Stage1-vs-Stage3 |
2.852600E-01 |
| Stage1-vs-Stage4 |
7.798600E-01 |
| Stage2-vs-Stage3 |
3.855200E-01 |
| Stage2-vs-Stage4 |
6.755200E-01 |
| Stage3-vs-Stage4 |
8.629200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.535000E-01 |
| Normal-vs-AfricanAmerican |
6.623400E-01 |
| Normal-vs-Asian |
4.242200E-01 |
| Caucasian-vs-AfricanAmerican |
9.340600E-01 |
| Caucasian-vs-Asian |
3.401400E-01 |
| AfricanAmerican-vs-Asian |
3.875600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.206400E-01 |
| Normal-vs-Female |
2.263000E-01 |
| Male-vs-Female |
1.275800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.998800E-01 |
| Normal-vs-Extreme_Weight |
1.670080E-02 |
| Normal-vs-Obese |
6.355200E-01 |
| Normal-vs-Extreme_Obese |
3.178200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.711200E-01 |
| Normal_Weight-vs-Obese |
2.190400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.743000E-01 |
| Extreme_Weight-vs-Obese |
1.712280E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.917800E-01 |
| Obese-vs-Extreme_Obese |
4.481000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.214600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.870600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.995200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.998700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.273400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.462200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.092210E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.323400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.398200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.119900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.791900E-02 |
| Normal-VS-Type2 PRCC |
8.452300E-02 |
| Normal-VS-KIRP CIMP |
7.320800E-01 |
| Normal-VS-Unclassified PRCC |
1.469160E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.773200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.293390E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.323920E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.961600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.108080E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.842800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.806400E-01 |
| Normal-vs-N1 |
7.866400E-01 |
| Normal-vs-N2 |
2.038200E-01 |
| N0-vs-N1 |
4.560800E-01 |
| N0-vs-N2 |
7.737000E-01 |
| N1-vs-N2 |
4.714600E-01 |
|
|
